Debut Plus

₹4.67

▼ -0.24 -4.89%

As of 26 Oct 2026 · delayed

NSE Listed · Pharmaceuticals

Lasa Supergenerics Ltd. (LASA)

Volume: 42,091Avg Vol 1W: 65,594Avg Vol 1M: 40,40352W Range:₹4.67₹12.48
NSE BSE www.lasalabs.com AI Report
Key Ratios
Checked 2h ago
Market Cap₹23 Cr
Current Price₹4.67
Previous Close₹4.91
High / Low (52w)₹12.48 / ₹4.67
Volume42,091
Avg Vol (1W)65,594
Avg Vol (1M)40,403
Stock P/E—
Book Value₹9.9
Dividend Yield0%
ROE-26.3%
ROA-24.96%
Revenue (TTM)—
Revenue Growth—
Profit Margin-260.06%
Total Debt—
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹0
P/B0.47
Debt / Equity0.09
50 DMA₹6.89
200 DMA₹7.97
Day change-4.89%
Price Chart
₹4.67▼ 55.98% · 1Y
₹16₹55.1L
2025-10-27
2026-10-26

20-day avg volume: 38K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 83% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹39 Cr₹33 Cr₹39 Cr₹20 Cr₹3 Cr₹2 Cr₹0 Cr₹1 Cr
EBITDA₹0 Cr₹-2 Cr₹2 Cr₹-2 Cr₹-6 Cr₹-2 Cr₹-3 Cr₹-3 Cr
Net Profit₹-3 Cr₹5 Cr₹-14 Cr₹-21 Cr₹-6 Cr₹-3 Cr₹-4 Cr₹-4 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹170 Cr₹167 Cr₹202 Cr₹137 Cr₹131 Cr₹104 Cr₹147 Cr₹25 Cr
EBITDA₹-8 Cr₹13 Cr₹31 Cr₹2 Cr₹-18 Cr₹-8 Cr₹-1 Cr₹-13 Cr
Net Profit₹-12 Cr₹4 Cr₹23 Cr₹-5 Cr₹-39 Cr₹-22 Cr₹-15 Cr₹-34 Cr
EPS-5.260.895.6-1.06-7.71-4.34-2.95-6.8
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹258 Cr₹232 Cr₹208 Cr₹209 Cr₹164 Cr₹151 Cr₹102 Cr₹66 Cr
Total Liabilities₹153 Cr₹91 Cr₹49 Cr₹51 Cr₹46 Cr₹54 Cr₹18 Cr₹17 Cr
Equity₹105 Cr₹141 Cr₹159 Cr₹158 Cr₹118 Cr₹97 Cr₹84 Cr₹50 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹41 Cr₹12 Cr₹-17 Cr₹2 Cr₹-3 Cr₹-8 Cr
Investing₹-4 Cr₹-3 Cr₹11 Cr₹0 Cr₹8 Cr₹0 Cr
Financing₹-36 Cr₹0 Cr₹-4 Cr₹-2 Cr₹-6 Cr₹7 Cr
Free Cash Flow₹41 Cr₹12 Cr₹-17 Cr₹2 Cr₹-3 Cr₹-8 Cr
Shareholding
Promoter 53.65% Institutions 0% Public 46.35%
Efficiency & Working Capital
ROCE-22.2%
Interest Coverage-31.4
Dividend Payout—
Debtor Days1 d
Inventory Days26 d
Payable Days31 d
Cash Conversion Cycle-4 d
Working Capital Days27 d
Shareholding Details

As of 2026-09-30

Promoter53.7%
FII0%
DII0%
Institutions0%
Public46.3%
Promoter Pledge20.7%
No. of Shareholders27,702
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Sept 2026
Promoters53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%
FIIs0%0%0.1%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public46.3%46.3%46.2%46.3%46.3%46.3%46.3%46.3%46.3%46.3%46.3%46.3%
Promoter Pledge20.7%20.7%20.7%20.7%20.7%20.7%20.7%20.7%20.7%20.7%20.7%20.7%
No. of Shareholders27,77027,16127,61527,21727,96927,27227,18827,18828,65628,12027,70227,702
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Omkar Pravin HerlekarShareholding of Promoter and Promoter Group53.7%2.69 Cr
Mahendra Girdharilal WadhwaniPublic Shareholding1%5,01,013
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Omkar Pravin Herlekar55,53,64920.7%2026-09-30
Board of Directors
NameDesignationYear
Omkar P HerlekarChairman / Executive Director / M D / Promoter2025
Prathamesh ChalkeE D & Wholetime Director2025
Ketan Bhau SongalIndependent Non Exe. Director2025
Pravin Gadalya LachakeIndependent Non Exe. Director2025
Yogesh Hari UghadaIndependent Non Exe. Director2025
Rekha Hemant WakhIndependent Non Exe. Director2025
Segments — Product
SegmentRevenueShare
Active Pharmaceutical Ingredients₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101,0005050
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000303
2026000202
2026000000
Insider / Designated-Person Trades

6 recent disclosure(s)

Vineeta Hitesh WadhwaniDisposal · 58,500
Vineeta Hitesh WadhwaniAcquisition · 1,71,428
Omkar Pravin HerlekarAcquisition · 90,71,429
Shivanand Gajanan HegdeAcquisition · 1,85,714
OMKAR PRAVIN HERLEKARInvoke · 7,00,343
OMKAR PRAVIN HERLEKARInvoke · 21,59,879
Company Information
Incorporated2016
ChairmanOmkar P Herlekar
AuditorGupta Rustagi & Co
Investor Email[email protected]
🌐 www.lasalabs.com ↗

📍 C-105 MIDC, Mahad, Raigad, Maharashtra, 402301

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Lamosaic India LimitedLancer Container Lines LimitedLancor Holdings LimitedLandmark Cars LimitedLandsmill Green LimitedLa Opala RGLaser Power & Infra Ltd.Latent View AnalyticsLatteys Industries Ltd.Laurus Labs LimitedLaxmi Cotspin LimitedLaxmi Dental LimitedAll “L” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search